Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma

This study has been withdrawn prior to enrollment.
(No participants enrolled.)
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00521092
First received: August 24, 2007
Last updated: May 2, 2014
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)